[A case of metastatic urinary bladder tumor from gastric carcinoma].
We report a case of metastatic bladder tumor from gastric carcinoma. A 55-year old male patient was referred to our urological clinic with a complaint of frequent urination and voiding pain. He had undergone total gastrectomy for poorly differentiated adenocarcinoma, signet-ring cell type, 9 months earlier. Computed tomographic scan revealed a thick bladder and rectum wall all around. Punch biopsies from vesical and rectal wall revealed metastatic adenocarcinoma, signet-ring cell type. There were no other metastatic sites. Systemic chemotherapy was done with a combination of mitomycin-C, 5-fluorouracil and cytosine arabinoside. This chemotherapy was effective and complete remission was obtained at bladder and rectum. Six months after chemotherapy, peritoneal recurrence developed and he died 9 months after chemotherapy. However no recurrence of bladder tumor was detected. This was a quite rare case of metastatic bladder tumor characterized by good response to systemic chemotherapy.
Nakamura
K
K
Department of Urology, Isehara Kyodo Hospital.
Hihara
T
T
Nishiumi
T
T
Yoneyama
T
T
D002288:Adenocarcinoma, Mucinous / Q000188:drug therapy / Q000556:secondary*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D009360:Neoplastic Cells, Circulating / Q000473:pathology; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000473:pathology*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000556:secondary*
D003561:Cytarabine; D016685:Mitomycin; D005472:Fluorouracil